Literature DB >> 17114909

Oxidative stress in the metabolic syndrome.

K Esposito1, M Ciotola, B Schisano, L Misso, G Giannetti, A Ceriello, D Giugliano.   

Abstract

The metabolic syndrome represents a cluster of several risk factors for atherosclerosis that increases the risk of future cardiovascular events. In this study, we evaluated whether oxidative stress is increased in subjects with the metabolic syndrome. We studied 100 subjects (50 men and 50 women) with the metabolic syndrome, as defined by the Adult Treatment Panel III, and 50 (25 men and 25 women) matched subjects without the syndrome. Insulin sensitivity was assessed with the homeostasis model assessment (HOMA) methods; endothelium-dependent flow-mediated vasodilation (FMD) was evaluated in the right brachial artery with a high-resolution ultrasound machine; oxidative stress was assessed by measuring the circulating levels of nitrotyrosine (NT), considered a good marker for the formation of endogenous peroxynitrite. Compared with control subjects, patients with the metabolic syndrome had greater waist circumference, higher HOMA and systolic pressure values, higher triglyceride and lower HDL-cholesterol levels. NT levels were higher (0.44+/-0.12 micromol/l, mean+/-SD) while FMD was lower [7.3 (4.4/9.6), median and interquartile range] in subjects with the metabolic syndrome as compared with control subjects [0.27+/-0.08 and 11.8 (8.6/14.9), respectively, p<0.001]. There was an increase in NT levels and HOMA score as the number of components of the metabolic syndrome increased. NT levels were associated with waist circumference (r=0.38, p=0.01), triglycerides (r=0.32, p<0.02), systolic blood pressure (r=0.21, p<0.05) and fasting glucose (r=0.24, p<0.05). The oxidative stress that accompanies the metabolic syndrome is associated with both insulin resistance and endothelial dysfunction, providing a connection which is highly deleterious for vascular functions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17114909     DOI: 10.1007/BF03347372

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  32 in total

1.  Obesity and oxidative stress: a direct link to CVD?

Authors:  Jane V Higdon; Balz Frei
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-03-01       Impact factor: 8.311

Review 2.  Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition.

Authors:  Scott M Grundy; H Bryan Brewer; James I Cleeman; Sidney C Smith; Claude Lenfant
Journal:  Circulation       Date:  2004-01-27       Impact factor: 29.690

Review 3.  Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I.

Authors:  Mark A Creager; Thomas F Lüscher; Francesco Cosentino; Joshua A Beckman
Journal:  Circulation       Date:  2003-09-23       Impact factor: 29.690

4.  Phagocytic NADPH oxidase overactivity underlies oxidative stress in metabolic syndrome.

Authors:  Ana Fortuño; Gorka San José; María U Moreno; Oscar Beloqui; Javier Díez; Guillermo Zalba
Journal:  Diabetes       Date:  2006-01       Impact factor: 9.461

5.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.

Authors:  Earl S Ford; Wayne H Giles; William H Dietz
Journal:  JAMA       Date:  2002-01-16       Impact factor: 56.272

Review 6.  Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-kappaB (Review).

Authors:  K A Roebuck
Journal:  Int J Mol Med       Date:  1999-09       Impact factor: 4.101

7.  Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

Authors:  A Festa; R D'Agostino; G Howard; L Mykkänen; R P Tracy; S M Haffner
Journal:  Circulation       Date:  2000-07-04       Impact factor: 29.690

Review 8.  Endothelial dysfunction, hemodynamic forces, and atherogenesis.

Authors:  M A Gimbrone; J N Topper; T Nagel; K R Anderson; G Garcia-Cardeña
Journal:  Ann N Y Acad Sci       Date:  2000-05       Impact factor: 5.691

9.  Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity.

Authors:  Boris Hansel; Philippe Giral; Estelle Nobecourt; Sandrine Chantepie; Eric Bruckert; M John Chapman; Anatol Kontush
Journal:  J Clin Endocrinol Metab       Date:  2004-10       Impact factor: 5.958

10.  Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting.

Authors:  PierMarco Piatti; Carlo Di Mario; Lucilla D Monti; Gabriele Fragasso; Fabio Sgura; Andrea Caumo; Emanuela Setola; Pietro Lucotti; Elena Galluccio; Cristina Ronchi; Anna Origgi; Ivana Zavaroni; Alberto Margonato; Antonio Colombo
Journal:  Circulation       Date:  2003-10-06       Impact factor: 29.690

View more
  15 in total

1.  Hyperglycemia, oxidative and nitrosative stress affect antiviral, inflammatory and apoptotic signaling of cultured thymocytes.

Authors:  G Kocic; D Sokolovic; T Jevtovic; A Veljkovic; R Kocic; G Nikolic; J Basic; D Stojanovic; A Cencic; S Stojanovic
Journal:  Redox Rep       Date:  2010       Impact factor: 4.412

2.  Crocetin attenuates palmitate-induced insulin insensitivity and disordered tumor necrosis factor-alpha and adiponectin expression in rat adipocytes.

Authors:  L Xi; Z Qian; G Xu; C Zhou; S Sun
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

3.  Effect of diesel exhaust inhalation on antioxidant and oxidative stress responses in adults with metabolic syndrome.

Authors:  Jason Allen; Carol A Trenga; Alon Peretz; Jeffrey H Sullivan; Christopher C Carlsten; Joel D Kaufman
Journal:  Inhal Toxicol       Date:  2009-11       Impact factor: 2.724

4.  Antioxidant and lipid-reducing effects of Rosa rugosa root extract in 3T3-L1 cell.

Authors:  Da-Hye Choi; Joon-Hee Han; Min Hong; Sun-Yeop Lee; Soo-Ung Lee; Tae-Hyung Kwon
Journal:  Food Sci Biotechnol       Date:  2021-12-18       Impact factor: 2.391

Review 5.  Inflammation, oxidative stress, and obesity.

Authors:  Alba Fernández-Sánchez; Eduardo Madrigal-Santillán; Mirandeli Bautista; Jaime Esquivel-Soto; Angel Morales-González; Cesar Esquivel-Chirino; Irene Durante-Montiel; Graciela Sánchez-Rivera; Carmen Valadez-Vega; José A Morales-González
Journal:  Int J Mol Sci       Date:  2011-05-13       Impact factor: 5.923

6.  The association between reactive oxygen metabolites and metabolic syndrome in asymptomatic Japanese men.

Authors:  Kazuhiko Kotani; Nobuyuki Taniguchi
Journal:  J Clin Med Res       Date:  2011-09-26

7.  Superparamagnetic iron oxide nanoparticles alter expression of obesity and T2D-associated risk genes in human adipocytes.

Authors:  S Sharifi; S Daghighi; M M Motazacker; B Badlou; B Sanjabi; A Akbarkhanzadeh; A T Rowshani; S Laurent; M P Peppelenbosch; F Rezaee
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

8.  Effect of combined mulberry leaf and fruit extract on liver and skin cholesterol transporters in high fat diet-induced obese mice.

Authors:  Giuseppe Valacchi; Giuseppe Belmonte; Clelia Miracco; Hyeyoon Eo; Yunsook Lim
Journal:  Nutr Res Pract       Date:  2014-01-29       Impact factor: 1.926

Review 9.  Secret talk between adipose tissue and central nervous system via secreted factors-an emerging frontier in the neurodegenerative research.

Authors:  Avinash Parimisetty; Anne-Claire Dorsemans; Rana Awada; Palaniyandi Ravanan; Nicolas Diotel; Christian Lefebvre d'Hellencourt
Journal:  J Neuroinflammation       Date:  2016-03-24       Impact factor: 8.322

10.  Association of serum paraoxonase enzyme activity and oxidative stress markers with dyslipidemia in obese adolescents.

Authors:  Moushira Erfan Zaki; Hala El-Bassyouni; Sanaa Kamal; Mona El-Gammal; Eman Youness
Journal:  Indian J Endocrinol Metab       Date:  2014-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.